Epstein David R
Director at TEM; Officer at Seagen Inc.; Director at Rubius Therapeutics, Inc.
- Sold, on record
- $4.4M
- Dollars the filings state
- Form 4 sales
- 18
- Latest Sep 1, 2026
- Form 144 notices
- 2
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- TEMTempus AI, Inc.Director
- Seagen Inc.Officer
- Rubius Therapeutics, Inc.Director
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- Rubius Therapeutics, Inc.125,441 shares
- Seagen Inc.10,620 shares
- TEM5,580 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale TEMRoutineSep 2 2025
Sold 250 shares at $73.64 ($18k)
Epstein David R, Director
10b5-1 planSold 0.9% of holdings ($2M position)27,041 shares left0.7x usual sizeFiling
- 2 Form 4 sale TEMRoutineNov 3 +62 days
Sold 370 shares at $90.00 ($33k)
Epstein David R, Director
10b5-1 planSold 1.4% of holdings ($2.4M position)26,671 shares left1x usual sizeFiling
- 3 Form 4 sale TEMRoutineDec 1 +28 days
Sold 250 shares at $75.55 ($19k)
Epstein David R, Director
10b5-1 planSold 0.9% of holdings ($2M position)26,421 shares left0.7x usual sizeFiling
- 4 Form 4 sale TEMRoutineFeb 2 +63 days
Sold 370 shares at $59.41 ($22k)
Epstein David R, Director
10b5-1 planSold 1.4% of holdings ($1.6M position)26,051 shares left1x usual sizeFiling
- 5 Form 4 sale TEMRoutineMar 2 +28 days
Sold 250 shares at $50.69 ($13k)
Epstein David R, Director
10b5-1 planSold 1% of holdings ($1.3M position)25,801 shares left0.7x usual sizeFiling
- 6 Form 4 sale TEMRoutineJun 1 +91 days
Sold 250 shares at $49.40 ($12k)
Epstein David R, Director
10b5-1 planSold 0.8% of holdings ($1.6M position)31,464 shares left0.7x usual sizeFiling
- 7 Form 4 sale TEMRoutineAug 3 +63 days
Sold 370 shares at $43.40 ($16k)
Epstein David R, Director
10b5-1 planSold 1.2% of holdings ($1.4M position)31,094 shares left1x usual sizeFiling
- 8 Form 4 sale TEMRoutineSep 1 +29 days
Sold 250 shares at $65.55 ($16k)
Epstein David R, Director
10b5-1 planSold 0.8% of holdings ($2M position)30,844 shares left0.7x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (20)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | TEM | Director | Form 4 sale | 250 | $16k | 0.8% | Routine | SEC |
| Aug 3, 2026 | TEM | Director | Form 4 sale | 370 | $16k | 1.2% | Routine | SEC |
| Jun 1, 2026 | TEM | Director | Form 4 sale | 250 | $12k | 0.8% | Routine | SEC |
| Mar 2, 2026 | TEM | Director | Form 4 sale | 250 | $13k | 1.0% | Routine | SEC |
| Feb 2, 2026 | TEM | Director | Form 4 sale | 370 | $22k | 1.4% | Routine | SEC |
| Dec 1, 2025 | TEM | Director | Form 4 sale | 250 | $19k | 0.9% | Routine | SEC |
| Nov 3, 2025 | TEM | Director | Form 4 sale | 370 | $33k | 1.4% | Routine | SEC |
| Sep 2, 2025 | TEM | Director | Form 4 sale | 250 | $18k | 0.9% | Routine | SEC |
| Aug 1, 2025 | TEM | Director | Form 4 sale | 370 | $20k | 1.3% | Routine | SEC |
| Jun 2, 2025 | TEM | Director | Form 4 sale | 250 | $14k | 0.9% | Routine | SEC |
| May 1, 2025 | TEM | Director | Form 4 sale | 370 | $20k | 1.4% | Routine | SEC |
| Mar 17, 2025 | TEM | Director | Form 4 sale | 990 | $46k | 3.6% | Routine | SEC |
| Mar 3, 2025 | TEM | Director | Form 4 sale | 250 | $14k | 0.9% | Routine | SEC |
| Feb 3, 2025 | TEM | Director | Form 4 sale | 370 | $20k | 1.3% | Routine | SEC |
| Dec 11, 2024 | TEM | Director | Form 4 sale | 620 | $26k | 2.2% | Routine | SEC |
| Dec 11, 2024 | TEM | Director | Form 144 notice | 1,240 | $56k | Notice | SEC | |
| Nov 13, 2023 | Seagen Inc. | Officer | Form 144 notice | 10,620 | $2.3M | Notice | SEC | |
| Nov 10, 2023 | Seagen Inc. | CEO | Form 4 sale | 10,620 | $2.3M | 7.2% | No plan | SEC |
| Feb 11, 2021 | Rubius Therapeutics, Inc. | Director | Form 4 sale | 26,704 | $399k | 0.6% | Plan not stated | SEC |
| Feb 10, 2021 | Rubius Therapeutics, Inc. | Director | Form 4 sale | 98,737 | $1.5M | 2.1% | Plan not stated | SEC |